Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause (VITAL-E)
Genitourinary Syndrome of Menopause
About this trial
This is an interventional treatment trial for Genitourinary Syndrome of Menopause
Eligibility Criteria
Inclusion Criteria: Able to provide informed consent Confirmed postmenopausal age Diagnosed genitourinary syndrome of menopause Access to a smartphone, tablet or computer, and to a functional email address. Exclusion Criteria: Contraindication for the use of estrogen therapy Unable to provide informed consent Patient unable to apply topical device Allergy or intolerance to ingredients or excipients of the formulation of studied products
Sites / Locations
- Orange Coast Women's Medical GroupRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
StrataMGT
Estrace
Participants will apply StrataMGT (silicone gel) 2-5 times daily (no limit in application times) to treat GSM for 3 months.
Participants will receive Estrace vaginal cream (estrogen) to treat GSM for 3 months. Application will be 1 g daily for the first two weeks. Afterwards, a maintenance dosage of 1 g three times a week is applied.